[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592611":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":38,"centralContacts":42,"locations":48,"responsibleParty":480,"collaborators":29,"id":482,"slug":483,"hasResults":484,"nctId":485,"briefTitle":486,"officialTitle":487,"acronym":488,"eligibilityCriteria":489,"healthyVolunteers":484,"sex":490,"minAge":491,"maxAge":29,"enrollmentInfo":492,"targetDuration":29,"studyType":495,"phases":496,"briefSummary":498,"conditions":499,"keywords":506,"overallStatus":51,"whyStopped":29,"lastUpdateSubmitDate":512,"lastUpdatePostDateStruct":513,"startDateStruct":516,"completionDateStruct":518,"leadSponsor":520,"locationsCount":521},{"fullName":5,"class":6},"Tyra Biosciences, Inc","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Dose Cohort A (DCA)","EXPERIMENTAL","TYRA-300 monotherapy in Participants with FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer",[13],"Drug: TYRA-300 60mg",{"label":15,"type":10,"description":11,"interventionNames":16},"Dose Cohort B (DCB)",[17],"Drug: TYRA-300 50mg",{"label":19,"type":10,"description":20,"interventionNames":21},"Possible Dose Cohort C (DCC)","To Be Determined- TYRA-300 monotherapy in Participants with FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer",[22],"Drug: TYRA-300 Dose TBD",[24,30,34],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":29},"DRUG","TYRA-300 60mg","Self-administered 60mg dose Oral tablet(s) given daily",[9],null,{"type":25,"name":31,"description":32,"armGroupLabels":33,"otherNames":29},"TYRA-300 50mg","Self-administered 50mg dose Oral tablet(s) given daily",[15],{"type":25,"name":35,"description":36,"armGroupLabels":37,"otherNames":29},"TYRA-300 Dose TBD","To Be Determined Dose: Self-administered Oral tablet(s) given daily",[19],[39],{"name":40,"affiliation":5,"role":41},"Doug Warner, MD","STUDY_CHAIR",[43],{"name":44,"role":45,"phone":46,"phoneExt":29,"email":47},"Gina Risdall","CONTACT","619-824-2509","TyraClinicalTrials@tyra.bio",[49,63,73,83,92,101,111,120,130,139,149,159,169,179,189,198,207,213,222,227,236,246,255,265,274,284,293,303,312,321,331,340,350,359,368,377,389,399,408,417,426,437,447,453,459,465,471],{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":29},"Urology Centers of Alabama","RECRUITING","Homewood","Alabama","35209","United States","US",{"type":58,"coordinates":59},"Point",[60,61],-86.80082,33.47177,{"lat":61,"lon":60},{"facility":64,"status":51,"city":65,"state":66,"zip":67,"country":55,"countryCode":56,"cosmosGeoPoint":68,"geoPoint":72,"contacts":29},"Arkansas Urology","Little Rock","Arkansas","72211",{"type":58,"coordinates":69},[70,71],-92.28959,34.74648,{"lat":71,"lon":70},{"facility":74,"status":51,"city":75,"state":76,"zip":77,"country":55,"countryCode":56,"cosmosGeoPoint":78,"geoPoint":82,"contacts":29},"Tri Valley Urology - Murrieta","Murrieta","California","92562",{"type":58,"coordinates":79},[80,81],-117.21392,33.55391,{"lat":81,"lon":80},{"facility":84,"status":51,"city":85,"state":76,"zip":86,"country":55,"countryCode":56,"cosmosGeoPoint":87,"geoPoint":91,"contacts":29},"Eisenhower Medical Associates","Rancho Mirage","92270",{"type":58,"coordinates":88},[89,90],-116.41279,33.73974,{"lat":90,"lon":89},{"facility":93,"status":51,"city":94,"state":76,"zip":95,"country":55,"countryCode":56,"cosmosGeoPoint":96,"geoPoint":100,"contacts":29},"Om Research LLC","San Diego","92123",{"type":58,"coordinates":97},[98,99],-117.16472,32.71571,{"lat":99,"lon":98},{"facility":102,"status":51,"city":103,"state":104,"zip":105,"country":55,"countryCode":56,"cosmosGeoPoint":106,"geoPoint":110,"contacts":29},"Associated Urological Specialists","Chicago Ridge","Illinois","60415",{"type":58,"coordinates":107},[108,109],-87.77922,41.70142,{"lat":109,"lon":108},{"facility":112,"status":51,"city":113,"state":104,"zip":114,"country":55,"countryCode":56,"cosmosGeoPoint":115,"geoPoint":119,"contacts":29},"Duly Health and Care","Lisle","60532",{"type":58,"coordinates":116},[117,118],-88.07479,41.80114,{"lat":118,"lon":117},{"facility":121,"status":51,"city":122,"state":123,"zip":124,"country":55,"countryCode":56,"cosmosGeoPoint":125,"geoPoint":129,"contacts":29},"Urology of Indiana","Greenwood","Indiana","46143",{"type":58,"coordinates":126},[127,128],-86.10665,39.61366,{"lat":128,"lon":127},{"facility":131,"status":51,"city":132,"state":123,"zip":133,"country":55,"countryCode":56,"cosmosGeoPoint":134,"geoPoint":138,"contacts":29},"First Urology","Jeffersonville","47130",{"type":58,"coordinates":135},[136,137],-85.73718,38.27757,{"lat":137,"lon":136},{"facility":140,"status":51,"city":141,"state":142,"zip":143,"country":55,"countryCode":56,"cosmosGeoPoint":144,"geoPoint":148,"contacts":29},"University of Kansas Medical Center (KUMC)","Kansas City","Kansas","66160",{"type":58,"coordinates":145},[146,147],-94.62746,39.11417,{"lat":147,"lon":146},{"facility":150,"status":51,"city":151,"state":152,"zip":153,"country":55,"countryCode":56,"cosmosGeoPoint":154,"geoPoint":158,"contacts":29},"Johns Hopkins University","Baltimore","Maryland","21205",{"type":58,"coordinates":155},[156,157],-76.61219,39.29038,{"lat":157,"lon":156},{"facility":160,"status":51,"city":161,"state":162,"zip":163,"country":55,"countryCode":56,"cosmosGeoPoint":164,"geoPoint":168,"contacts":29},"Greater Boston Urology","Plymouth","Massachusetts","02360",{"type":58,"coordinates":165},[166,167],-70.66726,41.95844,{"lat":167,"lon":166},{"facility":170,"status":51,"city":171,"state":172,"zip":173,"country":55,"countryCode":56,"cosmosGeoPoint":174,"geoPoint":178,"contacts":29},"Specialty Clinical Research of St. Louis","St Louis","Missouri","63141",{"type":58,"coordinates":175},[176,177],-90.19789,38.62727,{"lat":177,"lon":176},{"facility":180,"status":51,"city":181,"state":182,"zip":183,"country":55,"countryCode":56,"cosmosGeoPoint":184,"geoPoint":188,"contacts":29},"Atlantic Health System","Morristown","New Jersey","07960",{"type":58,"coordinates":185},[186,187],-74.48154,40.79677,{"lat":187,"lon":186},{"facility":190,"status":51,"city":191,"state":182,"zip":192,"country":55,"countryCode":56,"cosmosGeoPoint":193,"geoPoint":197,"contacts":29},"New Jersey Urology, LLC (Summit Health - Washington Township)","Voorhees Township","08043",{"type":58,"coordinates":194},[195,196],-74.49062,40.4795,{"lat":196,"lon":195},{"facility":199,"status":51,"city":200,"state":200,"zip":201,"country":55,"countryCode":56,"cosmosGeoPoint":202,"geoPoint":206,"contacts":29},"NYU Langone Health","New York","10016",{"type":58,"coordinates":203},[204,205],-74.00597,40.71427,{"lat":205,"lon":204},{"facility":208,"status":51,"city":200,"state":200,"zip":209,"country":55,"countryCode":56,"cosmosGeoPoint":210,"geoPoint":212,"contacts":29},"Memorial Sloan Kettering Cancer Center - Sidney Kimmel Center for Prostate and Urologic Cancers","10065",{"type":58,"coordinates":211},[204,205],{"lat":205,"lon":204},{"facility":214,"status":51,"city":215,"state":200,"zip":216,"country":55,"countryCode":56,"cosmosGeoPoint":217,"geoPoint":221,"contacts":29},"Associated Medical Professionals of NY","Syracuse","13210",{"type":58,"coordinates":218},[219,220],-76.14742,43.04812,{"lat":220,"lon":219},{"facility":223,"status":51,"city":215,"state":200,"zip":216,"country":55,"countryCode":56,"cosmosGeoPoint":224,"geoPoint":226,"contacts":29},"State University of New York (SUNY) Upstate Medical University",{"type":58,"coordinates":225},[219,220],{"lat":220,"lon":219},{"facility":228,"status":51,"city":229,"state":200,"zip":230,"country":55,"countryCode":56,"cosmosGeoPoint":231,"geoPoint":235,"contacts":29},"The Bronx Veterans Medical Research Foundation, Inc.","The Bronx","10468",{"type":58,"coordinates":232},[233,234],-73.86641,40.84985,{"lat":234,"lon":233},{"facility":237,"status":51,"city":238,"state":239,"zip":240,"country":55,"countryCode":56,"cosmosGeoPoint":241,"geoPoint":245,"contacts":29},"Duke Cancer Institute","Durham","North Carolina","27705",{"type":58,"coordinates":242},[243,244],-78.89862,35.99403,{"lat":244,"lon":243},{"facility":247,"status":51,"city":248,"state":239,"zip":249,"country":55,"countryCode":56,"cosmosGeoPoint":250,"geoPoint":254,"contacts":29},"Associate Urologist of North Carolina","Raleigh","27612",{"type":58,"coordinates":251},[252,253],-78.63861,35.7721,{"lat":253,"lon":252},{"facility":256,"status":51,"city":257,"state":258,"zip":259,"country":55,"countryCode":56,"cosmosGeoPoint":260,"geoPoint":264,"contacts":29},"The James at Brain and Spine Hospital (OSU)","Columbus","Ohio","43210",{"type":58,"coordinates":261},[262,263],-82.99879,39.96118,{"lat":263,"lon":262},{"facility":266,"status":51,"city":267,"state":258,"zip":268,"country":55,"countryCode":56,"cosmosGeoPoint":269,"geoPoint":273,"contacts":29},"Oregon Urology Institute","Springfield","97477",{"type":58,"coordinates":270},[271,272],-83.80882,39.92423,{"lat":272,"lon":271},{"facility":275,"status":51,"city":276,"state":277,"zip":278,"country":55,"countryCode":56,"cosmosGeoPoint":279,"geoPoint":283,"contacts":29},"MidLantic Urology","Bala-Cynwyd","Pennsylvania","19004",{"type":58,"coordinates":280},[281,282],-75.23407,40.00761,{"lat":282,"lon":281},{"facility":285,"status":51,"city":286,"state":277,"zip":287,"country":55,"countryCode":56,"cosmosGeoPoint":288,"geoPoint":292,"contacts":29},"Keystone Urology Specialists","Lancaster","17604",{"type":58,"coordinates":289},[290,291],-76.30551,40.03788,{"lat":291,"lon":290},{"facility":294,"status":51,"city":295,"state":296,"zip":297,"country":55,"countryCode":56,"cosmosGeoPoint":298,"geoPoint":302,"contacts":29},"Medical University of South Carolina","Charleston","South Carolina","29425",{"type":58,"coordinates":299},[300,301],-79.93275,32.77632,{"lat":301,"lon":300},{"facility":304,"status":51,"city":305,"state":296,"zip":306,"country":55,"countryCode":56,"cosmosGeoPoint":307,"geoPoint":311,"contacts":29},"Carolina Urologic Research Center","Myrtle Beach","29572",{"type":58,"coordinates":308},[309,310],-78.88669,33.68906,{"lat":310,"lon":309},{"facility":313,"status":51,"city":314,"state":296,"zip":315,"country":55,"countryCode":56,"cosmosGeoPoint":316,"geoPoint":320,"contacts":29},"Lowcounty Urology Clinics, P.A.","North Charleston","29406",{"type":58,"coordinates":317},[318,319],-79.97481,32.85462,{"lat":319,"lon":318},{"facility":322,"status":51,"city":323,"state":324,"zip":325,"country":55,"countryCode":56,"cosmosGeoPoint":326,"geoPoint":330,"contacts":29},"Conrad Pearson-Memphis","Germantown","Tennessee","38138",{"type":58,"coordinates":327},[328,329],-89.81009,35.08676,{"lat":329,"lon":328},{"facility":332,"status":51,"city":333,"state":324,"zip":334,"country":55,"countryCode":56,"cosmosGeoPoint":335,"geoPoint":339,"contacts":29},"Urology Associates PC","Nashville","37209",{"type":58,"coordinates":336},[337,338],-86.78444,36.16589,{"lat":338,"lon":337},{"facility":341,"status":51,"city":342,"state":343,"zip":344,"country":55,"countryCode":56,"cosmosGeoPoint":345,"geoPoint":349,"contacts":29},"Urology Austin","Austin","Texas","78759",{"type":58,"coordinates":346},[347,348],-97.74306,30.26715,{"lat":348,"lon":347},{"facility":351,"status":51,"city":352,"state":343,"zip":353,"country":55,"countryCode":56,"cosmosGeoPoint":354,"geoPoint":358,"contacts":29},"Urology Clinics of North Texas","Dallas","75231",{"type":58,"coordinates":355},[356,357],-96.80667,32.78306,{"lat":357,"lon":356},{"facility":360,"status":51,"city":361,"state":343,"zip":362,"country":55,"countryCode":56,"cosmosGeoPoint":363,"geoPoint":367,"contacts":29},"Baylor College of Medicine","Houston","77030",{"type":58,"coordinates":364},[365,366],-95.36327,29.76328,{"lat":366,"lon":365},{"facility":369,"status":51,"city":370,"state":343,"zip":371,"country":55,"countryCode":56,"cosmosGeoPoint":372,"geoPoint":376,"contacts":29},"Urology San Antonio","San Antonio","78229",{"type":58,"coordinates":373},[374,375],-98.49363,29.42412,{"lat":375,"lon":374},{"facility":378,"status":51,"city":379,"state":380,"zip":381,"country":382,"countryCode":383,"cosmosGeoPoint":384,"geoPoint":388,"contacts":29},"Epworth Freemasons-Victoria Parade","Richmond","Victoria","3121","Australia","AU",{"type":58,"coordinates":385},[386,387],145.00176,-37.81819,{"lat":387,"lon":386},{"facility":390,"status":51,"city":391,"state":392,"zip":29,"country":392,"countryCode":393,"cosmosGeoPoint":394,"geoPoint":398,"contacts":29},"Istituti Fisioterapici Ospitalieri (IFO)","Rome","Italy","IT",{"type":58,"coordinates":395},[396,397],12.51133,41.89193,{"lat":397,"lon":396},{"facility":400,"status":51,"city":401,"state":29,"zip":402,"country":392,"countryCode":393,"cosmosGeoPoint":403,"geoPoint":407,"contacts":29},"Istituto Europeo di Oncologia","Milan","20141",{"type":58,"coordinates":404},[405,406],9.18951,45.46427,{"lat":406,"lon":405},{"facility":409,"status":51,"city":410,"state":29,"zip":411,"country":392,"countryCode":393,"cosmosGeoPoint":412,"geoPoint":416,"contacts":29},"Azienda Ospedaliero Universitaria Pisana - Ospedale Santa Chiara","Pisa","56126",{"type":58,"coordinates":413},[414,415],10.4036,43.70853,{"lat":415,"lon":414},{"facility":418,"status":51,"city":419,"state":29,"zip":420,"country":392,"countryCode":393,"cosmosGeoPoint":421,"geoPoint":425,"contacts":29},"ASL Napoli 2 Nord - Ospedale Santa Maria delle Grazie","Pozzuoli","80078",{"type":58,"coordinates":422},[423,424],14.0952,40.84394,{"lat":424,"lon":423},{"facility":427,"status":51,"city":428,"state":429,"zip":430,"country":429,"countryCode":431,"cosmosGeoPoint":432,"geoPoint":436,"contacts":29},"Hospital del Mar","Barcelona","Spain","08003","ES",{"type":58,"coordinates":433},[434,435],2.15899,41.38879,{"lat":435,"lon":434},{"facility":438,"status":439,"city":440,"state":429,"zip":441,"country":429,"countryCode":431,"cosmosGeoPoint":442,"geoPoint":446,"contacts":29},"Hospital Clínico San Carlos","WITHDRAWN","Madrid","28040",{"type":58,"coordinates":443},[444,445],-3.70256,40.4165,{"lat":445,"lon":444},{"facility":448,"status":51,"city":440,"state":429,"zip":449,"country":429,"countryCode":431,"cosmosGeoPoint":450,"geoPoint":452,"contacts":29},"Hospital Universitario 12 de Oc","28041",{"type":58,"coordinates":451},[444,445],{"lat":445,"lon":444},{"facility":454,"status":51,"city":428,"state":29,"zip":455,"country":429,"countryCode":431,"cosmosGeoPoint":456,"geoPoint":458,"contacts":29},"Hospital Quirón Barcelona","08908",{"type":58,"coordinates":457},[434,435],{"lat":435,"lon":434},{"facility":460,"status":51,"city":440,"state":29,"zip":461,"country":429,"countryCode":431,"cosmosGeoPoint":462,"geoPoint":464,"contacts":29},"MD Anderson Cancer Center - Madrid","28003",{"type":58,"coordinates":463},[444,445],{"lat":445,"lon":444},{"facility":466,"status":51,"city":440,"state":29,"zip":467,"country":429,"countryCode":431,"cosmosGeoPoint":468,"geoPoint":470,"contacts":29},"Hospital Universitario Ramón y Cajal","28034",{"type":58,"coordinates":469},[444,445],{"lat":445,"lon":444},{"facility":472,"status":51,"city":473,"state":29,"zip":474,"country":429,"countryCode":431,"cosmosGeoPoint":475,"geoPoint":479,"contacts":29},"Hospital Universitario Marqués de Valdecilla","Santander","39008",{"type":58,"coordinates":476},[477,478],-3.80493,43.46589,{"lat":478,"lon":477},{"type":481,"investigatorFullName":29,"investigatorTitle":29,"investigatorAffiliation":29,"oldNameTitle":29,"oldOrganization":29},"SPONSOR","100592611","phase-2-efficacy-and-safety-of-tyra-300-in-participants-with-fgfr3-altered-low-grade-intermediate-risk-non-muscle-invasive-bladder-cancer-100592611",false,"NCT06995677","Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer","A Phase 2 Multicenter, Open-Label Study Evaluating the Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)","SURF302","Inclusion Criteria:\n\n* Participants age 18 and over of informed consent and willing and able to comply with all requires study procedures\n* Able to understand and given written informed consent\n* Participants with histologically confirmed low-grade NMIBC within 6 weeks prior to randomization with prior diagnostic biopsy\u002FTURBT to confirm stage and grade and with at least 3 mm and no more than 12 mm total (1\u002F2 a resectoscope loop to 2 loops, refer to Section 8.1.5) residual visible tumor as a marker lesion(s) left behind:\n\n  1. Ta low grade\n  2. T1 low grade\n* Participants must have intermediate risk NMIBC, defined as having any of the following characteristics (AUA Guidelines, 2024)\n\n  1. Recurrence within 1 year, LG Ta\n  2. Solitary LG Ta \\>3cm\n  3. LG Ta, multifocal\n  4. LG T1\n* Documented activating FGFR3 mutation or fusion (Appendix 4)\n* Have undergone bladder mapping and identification of visible marker lesion(s) within 6 weeks prior to randomization (refer to Inclusion Criterion #3)\n* No evidence of urothelial carcinoma of the upper urinary tract (confirmed by imaging) or prostatic urethra within 6 months of randomization\n* No prior BCG administration within 1 year of date of consent.\n* No intravesical chemotherapy within 8 weeks prior to C1D1.\n* ECOG 0-1\n* Pathology consistent with pure urothelial carcinoma; if mixed histology, ensure that at least 80% of the sample is urothelial\n* Adequate bone marrow, liver, and renal function:\n\n  b. Bone marrow function: i. Absolute neutrophil count (ANC) \\> or = 1,500\u002Fmm3 ii. Platelet count \\> or = 75,000\u002Fmm3 iii. \u002Fhemoglobin \\> or = 10.0 g\u002FdL e. Liver function: i.Total bilirubin \\\u003C or = ULN ii. Alanine aminotransferase (ALT) \\\u003C or = ULN iii. Aspartate aminotransferase (AST) \\\u003C or = ULN f. Renal function: i. estimated glomerular filtration rate \\>60 mL\u002Fmin calculated using the modification of diet in renal disease equation or CKD-EPI formula ii. Serum Phosphate level \\\u003C or = ULN prior to starting treatment g. Coagulation i. International normalized ratio (INR) \\\u003C or = 1.5 x ULN\n* Ability to swallow tablets\n* Participants (male and female) of child-bearing potential (including females who are post-menopausal for less than 1 year) must be willing to practice effective contraception while on treatment and be willing and able to continue contraception for 3 months (males) and 6 months (females) after the last dose of study treatment. Potential male participants should consider the potential impact of TYRA-300 on their ability to father a child and discuss options with the site study staff.\n* Potential participants who are positive for human immunodeficiency virus (HIV) must have a viral load below the limits of detection and on stable antiretroviral therapy for at least 3 months prior to C1D1. NOTE: some of the compounds in antiretroviral therapy may be on the prohibited medications list. Allowances will be made to ensure the participant's HIV treatment continues uninterrupted following a discussion with the Sponsor's medical monitor. A discussion of the impact of the antiretroviral therapy on TYRA- 300 needs to be discussed with the potential participant prior to C1D1.\n* Potential participants with chronic hepatitis B virus (HBV) infection with active disease should be on a suppressive antiviral therapy prior to C1D1.\n* Potential participants patients with a history of hepatitis C virus (HCV) infection should have completed curative antiviral treatment and must have a HCV viral load below the limit of quantification.\n* Potential participants with a history of HCV infection and on current treatment must have a HCV viral load below the limit of quantification\n\nExclusion Criteria:\n\n* Presence of tumor in ureter or prostatic urethra:\n* Current or previous history of muscle invasive bladder cancer\n* Current or previous history of lymph node positive and\u002For metastatic bladder cancer\n* Evidence of pure squamous cell carcinoma, pure adenocarcinoma or pure undifferentiated carcinoma of the bladder\n* Currently receiving systemic cancer therapy (cytotoxic, immunotherapy, targeted)\n* Currently receiving treatment with a prohibited therapy (refer to Section 6.7.1)\n* Current or prior history of pelvic external beam radiotherapy\n* Current or history of receiving a prior FGFR inhibitor\n* Systemic immunotherapy within 6 months prior to randomization\n* Treatment with an investigational agent within 30 days or 5 half-lives from randomization, whichever is shorter; compounds with an unknown half-life will default to the 30 days.\n* Prior treatment with an intravesical agent within 8 weeks prior to C1D1\n* Current ongoing toxicity from previous therapy\n* Had major surgery within 4 weeks prior to C1D1\n* Any reason that in the view of the investigator, would substantially impair the ability of the participant to comply with study procedures and\u002For risk to the participant (i.e., uncontrolled diabetes)\n* Females who are pregnant, breastfeeding or planning to become pregnant within 6 months after the last dose of TYRA-300 and males who plan to father a child while enrolled in this study or within 3 months after the last dose of TYRA-300\n* Has impaired wound healing capacity\n* Serum phosphate levels above the upper limit of normal during screening\n* Any ocular condition likely to increase the risk of eye toxicity\n* Current evidence of central serous retinopathy or retinal pigmented epithelial detachment of any grade at time of baseline examination.\n* History of or current uncontrolled cardiovascular disease\n* Gastrointestinal disorders that will affect oral administration or absorption of TYRA-300\n* Known history of HIV infection, or active hepatitis B or C\n* History of a second primary malignancy within 3 years of signing ICF, except for nonmelanoma skin cancer and cured and active surveillance malignancies (i.e., prostate, breast) .\n* Known allergy to TYRA-300 or any excipients of the formulated product\n* Participants taking strong inhibitors and\u002For inducers of CYP3A4 enzyme\n* History of prolonged QT syndrome or baseline heart rate-corrected QT interval using Fridericia formula (QTcF) interval \\>470 ms","ALL","18 Years",{"count":493,"type":494},90,"ESTIMATED","INTERVENTIONAL",[497],"PHASE2","Phase 2 Study of TYRA-300 in FGFR3 Altered Low Grade, Intermediate Risk NMIBC",[500,501,502,503,504,505],"Low-grade NMIBC","FGFR Gene Amplification","FGFR Gene Alterations","FGFR3 Gene Alteration","FGFR3 Gene Mutation","FGFR3 Gene Fusions",[507,508,509,510,511],"FGFR3 gene alterations","FGFR3 gene mutations","FGFR3 gene fusions","FGFR3","Non-Muscle Invasive Bladder Cancer","2026-08-04",{"date":514,"type":515},"2026-08-06","ACTUAL",{"date":517,"type":515},"2025-06-27",{"date":519,"type":494},"2028-09",{"name":5,"class":6},47]